358 related articles for article (PubMed ID: 30381462)
1. p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression.
Amelio I; Mancini M; Petrova V; Cairns RA; Vikhreva P; Nicolai S; Marini A; Antonov AA; Le Quesne J; Baena Acevedo JD; Dudek K; Sozzi G; Pastorino U; Knight RA; Mak TW; Melino G
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10869-E10878. PubMed ID: 30381462
[TBL] [Abstract][Full Text] [Related]
2. Micheliolide Enhances Radiosensitivities of p53-Deficient Non-Small-Cell Lung Cancer via Promoting HIF-1α Degradation.
Kong P; Yu KN; Yang M; Almahi WA; Nie L; Chen G; Han W
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403326
[TBL] [Abstract][Full Text] [Related]
3. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.
Grosso S; Doyen J; Parks SK; Bertero T; Paye A; Cardinaud B; Gounon P; Lacas-Gervais S; Noël A; Pouysségur J; Barbry P; Mazure NM; Mari B
Cell Death Dis; 2013 Mar; 4(3):e544. PubMed ID: 23492775
[TBL] [Abstract][Full Text] [Related]
4. BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I.
Ellinghaus P; Heisler I; Unterschemmann K; Haerter M; Beck H; Greschat S; Ehrmann A; Summer H; Flamme I; Oehme F; Thierauch K; Michels M; Hess-Stumpp H; Ziegelbauer K
Cancer Med; 2013 Oct; 2(5):611-24. PubMed ID: 24403227
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.
Ali A; Bhatti MZ; Shah AS; Duong HQ; Alkreathy HM; Mohammad SF; Khan RA; Ahmad A
J Biol Chem; 2015 Aug; 290(35):21336-51. PubMed ID: 25911104
[TBL] [Abstract][Full Text] [Related]
6. Plakoglobin restores tumor suppressor activity of p53
Alaee M; Nool K; Pasdar M
Cancer Sci; 2018 Jun; 109(6):1876-1888. PubMed ID: 29660231
[TBL] [Abstract][Full Text] [Related]
7. Introduction of hypoxia-targeting p53 fusion protein for the selective therapy of non-small cell lung cancer.
Zhao Y; Wu S; Wu J; Jia P; Gao S; Yan X; Wang Y
Cancer Biol Ther; 2011 Jan; 11(1):95-107. PubMed ID: 21248471
[TBL] [Abstract][Full Text] [Related]
8. A lineage-tracing tool to map the fate of hypoxic tumour cells.
Vermeer JAF; Ient J; Markelc B; Kaeppler J; Barbeau LMO; Groot AJ; Muschel RJ; Vooijs MA
Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32571767
[TBL] [Abstract][Full Text] [Related]
9. p53 inhibits vascular endothelial growth factor expression in solid tumor.
Yoshioka Y; Shimizu S; Ito T; Taniguchi M; Nomura M; Nishida T; Sawa Y
J Surg Res; 2012 May; 174(2):291-7. PubMed ID: 21324396
[TBL] [Abstract][Full Text] [Related]
10. CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation.
Chavdoula E; Habiel DM; Roupakia E; Markopoulos GS; Vasilaki E; Kokkalis A; Polyzos AP; Boleti H; Thanos D; Klinakis A; Kolettas E; Marcu KB
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31792060
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced cytosine deaminase gene expression for cancer therapy.
Lee CH; Wu CL; Shiau AL
Hum Gene Ther; 2007 Jan; 18(1):27-38. PubMed ID: 17184154
[TBL] [Abstract][Full Text] [Related]
12. p53 upregulated by HIF-1α promotes hypoxia-induced G2/M arrest and renal fibrosis in vitro and in vivo.
Liu L; Zhang P; Bai M; He L; Zhang L; Liu T; Yang Z; Duan M; Liu M; Liu B; Du R; Qian Q; Sun S
J Mol Cell Biol; 2019 May; 11(5):371-382. PubMed ID: 30032308
[TBL] [Abstract][Full Text] [Related]
13. p53 gain-of-function mutations increase Cdc7-dependent replication initiation.
Datta A; Ghatak D; Das S; Banerjee T; Paul A; Butti R; Gorain M; Ghuwalewala S; Roychowdhury A; Alam SK; Das P; Chatterjee R; Dasgupta M; Panda CK; Kundu GC; Roychoudhury S
EMBO Rep; 2017 Nov; 18(11):2030-2050. PubMed ID: 28887320
[TBL] [Abstract][Full Text] [Related]
14. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells.
Deng WG; Kawashima H; Wu G; Jayachandran G; Xu K; Minna JD; Roth JA; Ji L
Cancer Res; 2007 Jan; 67(2):709-17. PubMed ID: 17234782
[TBL] [Abstract][Full Text] [Related]
15. Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environment.
Mayes PA; Campbell L; Ricci MS; Plastaras JP; Dicker DT; El-Deiry WS
Cancer Biol Ther; 2005 Oct; 4(10):1068-74. PubMed ID: 16294025
[TBL] [Abstract][Full Text] [Related]
16. The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.
Van Nostrand JL; Brisac A; Mello SS; Jacobs SB; Luong R; Attardi LD
Cancer Discov; 2015 Jun; 5(6):622-35. PubMed ID: 25813352
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation.
Chi Y; Luo Q; Song Y; Yang F; Wang Y; Jin M; Zhang D
J Cell Biochem; 2019 Nov; 120(11):19019-19030. PubMed ID: 31241217
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells.
Yoshikawa K; Hamada J; Tada M; Kameyama T; Nakagawa K; Suzuki Y; Ikawa M; Hassan NM; Kitagawa Y; Moriuchi T
Biomed Res; 2010 Dec; 31(6):401-11. PubMed ID: 21187651
[TBL] [Abstract][Full Text] [Related]
19. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer.
Tesei A; Arienti C; Bossi G; Santi S; De Santis I; Bevilacqua A; Zanoni M; Pignatta S; Cortesi M; Zamagni A; Storci G; Bonafè M; Sarnelli A; Romeo A; Cavallo C; Bartolazzi A; Rossi S; Soriani A; Strigari L
J Exp Clin Cancer Res; 2021 Mar; 40(1):89. PubMed ID: 33673859
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein.
Liu M; Zhong J; Zeng Z; Huang K; Ye Z; Deng S; Chen H; Xu F; Li Q; Zhao G
Theranostics; 2019; 9(16):4795-4810. PubMed ID: 31367258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
